tiprankstipranks
Trending News
More News >
Revive Therapeutics Ltd (TSE:RVV)
:RVV
Canadian Market

Revive Therapeutics (RVV) Income Statement

Compare
133 Followers

Revive Therapeutics Income Statement

Last quarter (Q3 2025), Revive Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Revive Therapeutics's net income was C$-577.18K. See Revive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -328.00C$ -434.00C$ -578.00C$ -775.00C$ -28.27K
Operating Expenses
C$ 3.29MC$ 5.52MC$ 17.83MC$ 18.59MC$ 3.68M
Depreciation and Amortization
C$ 328.00C$ 434.00C$ 578.00C$ 775.00C$ 28.27K
EBITDA
C$ -5.60MC$ -5.52MC$ -17.74MC$ -18.57MC$ -5.26M
Operating Income
C$ -3.29MC$ -5.52MC$ -17.83MC$ -18.50MC$ -4.84M
Other Income/Expenses
C$ -2.33MC$ -796.15KC$ 26.10KC$ -1.55MC$ -1.72M
Pretax Income
C$ -5.62MC$ -6.32MC$ -17.81MC$ -20.12MC$ -5.38M
Net Income
C$ -5.62MC$ -6.32MC$ -17.83MC$ -20.20MC$ -5.38M
Per Share Metrics
Basic EPS
C$ -0.01C$ -0.02C$ -0.06C$ -0.08C$ -0.04
Diluted EPS
C$ -0.01C$ -0.02C$ -0.06C$ -0.08C$ -0.04
Weighted Average Shares Outstanding
380.48M 339.37M 319.76M 267.49M 106.88M
Weighted Average Shares Outstanding (Diluted)
380.48M 339.37M 319.76M 267.49M 106.88M
Currency in CAD

Revive Therapeutics Earnings and Revenue History